Cartilage Regeneration
Regrow the smooth joint cartilage that wears away
The goal is to regrow healthy joint cartilage — the smooth, living cushion that lets joints glide painlessly — so that a worn or damaged joint can be rebuilt rather than merely managed or replaced. Not an artificial joint. The return of the body’s own living cartilage.
Cartilage is the smooth tissue that caps the bones in every joint, letting them move without pain. It has a cruel design flaw: it has no blood supply, no nerves, and no lymphatic drainage, so once it is damaged it barely heals on its own. The slow wearing-away of cartilage is osteoarthritis — the world’s leading cause of joint pain and disability, affecting hundreds of millions. Regrowing real cartilage would let people keep their own joints, moving freely and without pain, instead of losing them to wear. That is why cartilage regeneration is the flagship of the joints.
We are building the capability to regrow durable, properly-structured joint cartilage: cartilage that bonds to the bone beneath it, withstands a lifetime of load, and recreates the smooth gliding surface — using the patient’s own cells, engineered tissue, or scaffolds that guide the body to rebuild the joint surface.
Growing cartilage from cells, scaffolds, and bioprinting
Regrowing cartilage from stem cells Advancing — some clinical
Mesenchymal stem cells and iPSCs can be turned into cartilage-making cells (chondrocytes) and delivered to a damaged joint to regrow cartilage; some cell-and-scaffold approaches are already in clinical use.
Scaffold-guided regeneration Clinical
Multilayered scaffolds that recreate cartilage’s structure — and bond it to bone — guide the body to rebuild the joint surface, with several approaches now clinical.
3D-bioprinting joint tissue Frontier
Bioprinting builds cartilage with the precise layered architecture of the real tissue, a route to custom joint-surface repair.
Joint-on-a-chip testing Demonstrated
Lab models of the joint let researchers test regenerative therapies quickly and precisely before they reach patients.
Cited as evidence the capability is real — not as partners or endorsers.
Universities & institutes
Academic orthopedic, tissue-engineering, and regenerative-medicine centers developing cell therapies, scaffolds, and bioprinting for cartilage.
Government & programs
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, NIH) · NIH and DoD regenerative-medicine and musculoskeletal programs · AFIRM (Armed Forces Institute of Regenerative Medicine).
Enabling science base
mesenchymal & iPSC-derived chondrocytes · multilayered scaffolds · 3D bioprinting · cartilage tissue engineering · joint-on-a-chip models.
The technologies: cell therapies using mesenchymal stem cells and iPSC-derived chondrocytes; engineered scaffolds — including multilayered designs that bond cartilage to bone; 3D bioprinting that reproduces cartilage’s precise layered structure; and joint-on-a-chip models that accelerate testing. Together they aim to rebuild not just a patch of cartilage but a durable, integrated joint surface.
Scaffold cartilage repair in the clinic Clinical
Several multilayered-scaffold and cell-based cartilage-repair approaches have reached clinical use, regrowing cartilage in damaged joints.
Stem-cell cartilage formation Demonstrated
Mesenchymal and iPSC-derived cells reliably form cartilage tissue in the lab and in animal joints — the cellular foundation of regeneration.
Bioprinted cartilage structures Demonstrated in research
3D-bioprinted cartilage with realistic layered architecture has been produced in research, advancing toward custom joint repair.
Integration with bone Clinical
Newer scaffolds specifically address bonding new cartilage to the bone beneath — a key to durable repair.
The honest challenges: the hardest problem is making regrown cartilage as durable as the original and getting it to bond permanently to bone — repairs can be less tough than natural cartilage and may wear. Scale: small defects are far easier than the widespread wear of advanced osteoarthritis. The avascular environment that stops natural healing also makes regeneration hard. Some scaffold and cell approaches are clinical for focused damage; regrowing a whole osteoarthritic joint surface remains advancing-to-frontier, and we label each stage honestly.
The future, fully built
A person with a worn or injured joint — facing pain and lost motion — has their cartilage regrown: a smooth, living, durable joint surface rebuilt from their own cells, bonded to bone, gliding without pain. They keep their own joint, moving freely, instead of losing it to wear. Joint cartilage becomes something we regrow, not just a tissue that wears out.
The proof, for this capability
Cited as evidence the capability is real, not as partners or endorsers.
Clinical scaffold & cell cartilage repair
Multilayered scaffolds and cell-based therapies have reached clinical use for focused cartilage damage, regrowing the joint surface. Stage: Clinical.
Stem-cell-derived chondrocytes
Mesenchymal and iPSC-derived cells reliably form cartilage in lab and animal studies. Stage: Demonstrated.
3D-bioprinted cartilage
Bioprinted cartilage with realistic layered structure produced in research. Stage: Demonstrated (research).
Honest framing
Real organizations and studies are cited as evidence the capability is real — not as partners or endorsers. Regrowing a whole arthritic joint surface is not yet routine; we do not claim it is.
Help build this future
Every signature grows the movement to make cartilage regeneration real — and free at the point of need.